Nuala Moran

Consumer products giant Procter and Gamble is applying its knowledge of consumers to the development of new medicines – and wants to share its insights with biotech companies.

The continuing argument over first-generation GMcrops has created a huge roadblock to more refined agbiotech developments, says Nuala Moran

Follow the fashion: the biotech financing model has changed. But will today’s start-ups be tomorrow’s fashion victims?

PepsiCo’s $5.2 million donation to look at lifestyle and chronic disease looks like an act of the archest cynicism. But someone needs to do something, says Nuala Moran.

A major survey shows confidence holding steady as early-stage funding eases slightly – and the relationship with big pharma improves.

The UK Conservative Party has joined the tidal wave of opinion arguing that the European Union needs to use its public procurement budget to drive innovation.

Animal models of human disease are the foundation stone of drug development. Now new data show they routinely overstate how effective drugs are.

The European Commission has laid out a new strategy for financing the parlous Galileo global positioning system and getting the European Institute of Technology off the ground.

It may come near the top of international rankings for its innovation performance, but Nokia’s top research manager thinks Denmark still needs to do better.

The UK's seven research councils have set out a strategy to internationalise their activities to pull in more researchers from overseas and enable cross country funding of projects.